This is in stark contrast to cutaneous melanoma, where B-Raf proto-oncogene, serine/threonine kinase (BRAF) and neuroblastoma RAS viral oncogene homolog (NRAS) mutations predominate [4,5]. This evidence concerns the gene NRAS and cutaneous melanoma.